vTv Therapeutics VTVT
NASDAQ VTVT
$30.57 -1.28 (-4.02%)
At close: Oct 2, 2026 · 4:00 PM EDT

vTv Therapeutics (VTVT) Price to Book (2024 - 2026)

Updated

vTv Therapeutics' Price to Book was 5.94 in Q2 2026, down 85.5% from 41.08 a year earlier but up 8.6% from the prior quarter.

Analysis

vTv Therapeutics (VTVT) Price to Book (2024 - 2026) Analysis & Trends

For FY2025, Price to Book at vTv Therapeutics came in at 5.23, down 6.2% from FY2024.

  • In earlier years, Price to Book was 5.57 in FY2024.
  • Quarterly Price to Book has moved between 2.67 (Q3 2025) and 41.08 (Q2 2025) over five years.
  • Compared with a year earlier, Price to Book has declined for four straight quarters, with growth averaging 116.6% over the last six quarters.
  • Per Business Quant data, VTVT's Price to Book in the three quarters before Q2 2026 was 5.47 (Q1 2026), 5.23 (Q4 2025) and 2.67 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 vTv Therapeutics 379.35 Mn 379.35 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 5.94
Mar 31, 2026 5.47
Dec 31, 2025 5.23
Sep 30, 2025 2.67
Jun 30, 2025 41.08
Mar 31, 2025 12.81
Dec 31, 2024 5.57
Sep 30, 2024 4.13
Jun 30, 2024 5.53
Mar 31, 2024 3.75
API Access

vTv Therapeutics Price to Book API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=price-to-book&ticker=VTVT&period=max&api_key=YOUR_API_KEY